ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 253 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2016. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $499,000 | +138.8% | 32,730 | +13.3% | 0.01% | +40.0% |
Q1 2020 | $209,000 | -18.0% | 28,882 | +11.4% | 0.01% | +11.1% |
Q4 2019 | $255,000 | +20.3% | 25,922 | +30.0% | 0.01% | +12.5% |
Q3 2019 | $212,000 | -7.8% | 19,945 | -0.6% | 0.01% | +14.3% |
Q2 2019 | $230,000 | +107.2% | 20,057 | +73.1% | 0.01% | +40.0% |
Q1 2019 | $111,000 | +8.8% | 11,589 | +9.7% | 0.01% | 0.0% |
Q4 2018 | $102,000 | -21.5% | 10,561 | +15.8% | 0.01% | 0.0% |
Q3 2018 | $130,000 | +120.3% | 9,121 | +11.8% | 0.01% | +25.0% |
Q2 2018 | $59,000 | -11.9% | 8,161 | +47.3% | 0.00% | 0.0% |
Q1 2018 | $67,000 | -8.2% | 5,541 | +14.3% | 0.00% | -20.0% |
Q4 2017 | $73,000 | +23.7% | 4,849 | +16.6% | 0.01% | 0.0% |
Q3 2017 | $59,000 | -61.2% | 4,157 | -65.3% | 0.01% | -61.5% |
Q2 2017 | $152,000 | +660.0% | 11,964 | +494.0% | 0.01% | -86.0% |
Q4 2016 | $20,000 | -45.9% | 2,014 | -29.8% | 0.09% | +19.2% |
Q3 2016 | $37,000 | -36.2% | 2,868 | -37.3% | 0.08% | +85.7% |
Q1 2016 | $58,000 | – | 4,577 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |